Literature DB >> 1917950

Transactivation functions facilitate the disruption of chromatin structure by estrogen receptor derivatives in vivo.

T A Pham1, Y P Hwung, D P McDonnell, B W O'Malley.   

Abstract

The activation of gene transcription by nuclear receptors is invariably associated with alterations in chromatin structure at hormone-responsive elements of target genes. To identify the molecular functions underlying receptor-mediated chromatin structure alterations we have evaluated the effects of DNA binding and transactivation of estrogen receptor derivatives on the promoter chromatin structure of estrogen-responsive reporter minichromosomes in Saccharomyces cerevisiae. We report here that the DNase I-hypersensitive chromatin structure at the promoter region is not simply a consequence of estrogen receptor binding to estrogen-responsive elements but is greatly enhanced by transactivation functions. These chromatin structure alterations are dependent on the presence of more than one estrogen-responsive element as well as downstream promoter sequences and appear to be correlated with transcriptional competence of the promoter. Our results imply that a disruption of chromatin structure at promoters is associated with the establishment of active transcription complexes. Since RNA polymerase cannot initiate transcription on nucleosomal DNA in vitro (Lorch, Y., Lapointe, J.W., and Kornberg, R.D. (1987) Cell 49, 203-210) this local disruption of chromatin structure may represent a nucleosome-free window, allowing initiation to occur in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917950

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Ligand dependence of estrogen receptor induced changes in chromatin structure.

Authors:  D M Gilbert; R Losson; P Chambon
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Role for ADA/GCN5 products in antagonizing chromatin-mediated transcriptional repression.

Authors:  K J Pollard; C L Peterson
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Role of the histone amino termini in facilitated binding of a transcription factor, GAL4-AH, to nucleosome cores.

Authors:  M Vettese-Dadey; P Walter; H Chen; L J Juan; J L Workman
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

4.  Chromatin structure modulation in Saccharomyces cerevisiae by centromere and promoter factor 1.

Authors:  N A Kent; J S Tsang; D J Crowther; J Mellor
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast.

Authors:  D Metzger; R Losson; J M Bornert; Y Lemoine; P Chambon
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

6.  Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex.

Authors:  A K Ostlund Farrants; P Blomquist; H Kwon; O Wrange
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

7.  Direct study of DNA-protein interactions in repressed and active chromatin in living cells.

Authors:  M P Kladde; M Xu; R T Simpson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator.

Authors:  E M McInerney; M J Tsai; B W O'Malley; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor.

Authors:  H Htun; L T Holth; D Walker; J R Davie; G L Hager
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

10.  Identification of a negative regulatory function for steroid receptors.

Authors:  D P McDonnell; E Vegeto; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.